
Cortalix BV
A cutting-edge platform of synthetic laboratories dedicated to developing single-domain antibodies
About Cortalix BV
Cortalix was founded in 2023 and focuses on nanobody technology and PET imaging. The company develops single-domain antibodies for PET imaging, radiotherapy, and CAR-T immunotherapy.
Legal Name
: Cortalix BV
Headquarters
: , Netherlands
Business Model
:
No. of Employees
:








